Castle Biosciences Chief Commercial Officer Tobin W Juvenal reports sale of $110,608.32 in common shares
CSTL•Castle Biosciences Chief Commercial Officer Tobin W Juvenal sold 3,288 common shares on October 12, 2026, at $33.64 per share. He held 48,719 shares directly afterward.
1. Share sale
Tobin W Juvenal sold 3,288 Castle Biosciences common shares on October 12, 2026, at $33.64 per share. The sale was valued at $110,608.32, and he held 48,719 shares directly afterward.
